Sign In
Buy IONS
$73.82
+0.85 (+1.16%)
At Close: Jun 03, 2026
Agios Pharma (AGIO) Gets a Buy Rating from Needham
03:27pm, Thursday, 30'th Apr 2020
In a report released today,
Chad Messer
from Needham maintained a
Buy
rating on Agios Pharma (
AGIO
–
Research Report
), with a price target of
$71.00
. The company’s shares closed last Thursday a
William Blair Reiterates Their Buy Rating on Neurocrine (NBIX)
11:38am, Thursday, 30'th Apr 2020
William Blair analyst Myles Minter reiterated a Buy rating on Neurocrine (NBIX) on April 27. The company's shares closed last Wednesday at $100.91.
William Blair Reiterates Their Buy Rating on Neurocrine (NBIX)
11:38am, Thursday, 30'th Apr 2020
William Blair analyst
Myles Minter
reiterated a
Buy
rating on Neurocrine (
NBIX
–
Research Report
) on April 27. The company’s shares closed last Wednesday at $100.91.
According to
TipRanks.com
,
Earnings Preview: Ionis Pharmaceuticals (IONS) Q1 Earnings Expected to Decline
04:34pm, Wednesday, 29'th Apr 2020
Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Ionis Pharmaceuticals, Inc.’s (NASDAQ:IONS) Stock’s Recent Performance Being Led By Its Attractive Financial Prospects?
11:55am, Wednesday, 29'th Apr 2020
Ionis Pharmaceuticals (NASDAQ:IONS) has had a great run on the share market with its stock up by a significant 19...
Roche's risdiplam successful in pivotal SMA study
10:44am, Tuesday, 28'th Apr 2020
Roche (OTCQX:RHHBY) announces positive results from the second part of a Phase 2/3 clinical trial, FIREFISH, evaluating risdiplam in infants aged 1-7 months with symptomatic spinal muscular atrophy ty
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and CTI BioPharma (CTIC)
06:27pm, Monday, 27'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurocrine (NBIX) and CTI BioPharma (CTIC). Neurocrine (NBIX) In a
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and CTI BioPharma (NASDAQ: CTIC)
06:27pm, Monday, 27'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurocrine (
NBIX
–
Research Report
) and CTI BioPharma (
CTIC
–
Research Report
).
Neurocrine (NBIX)
In a report
Lincoln National Corp Reduces Stake in Ionis Pharmaceuticals Inc (NASDAQ:IONS)
11:32am, Monday, 27'th Apr 2020
Lincoln National Corp reduced its position in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 4.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Expected to Announce Quarterly Sales of $160.04 Million
09:00am, Monday, 27'th Apr 2020
Analysts expect Ionis Pharmaceuticals Inc (NASDAQ:IONS) to report sales of $160.04 million for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Ionis Phar
Q1 2020 EPS Estimates for Ionis Pharmaceuticals Inc Decreased by Analyst (NASDAQ:IONS)
05:04am, Monday, 27'th Apr 2020
Ionis Pharmaceuticals Inc (NASDAQ:IONS) – Stock analysts at SVB Leerink decreased their Q1 2020 EPS estimates for Ionis Pharmaceuticals in a research report issued to clients and investors on Wednes
Coastal Investment Advisors Inc. Trims Stock Position in Ionis Pharmaceuticals Inc (NASDAQ:IONS)
10:38am, Saturday, 25'th Apr 2020
Coastal Investment Advisors Inc. decreased its position in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 12.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securiti
Ionis Pharmaceuticals Inc to Post FY2020 Earnings of ($0.18) Per Share, SVB Leerink Forecasts (NASDAQ:IONS)
09:26am, Saturday, 25'th Apr 2020
Ionis Pharmaceuticals Inc (NASDAQ:IONS) – Research analysts at SVB Leerink dropped their FY2020 earnings per share (EPS) estimates for Ionis Pharmaceuticals in a report issued on Tuesday, April 21st
Ionis Pharmaceuticals Inc (NASDAQ:IONS) to Post Q1 2020 Earnings of ($0.40) Per Share, William Blair Forecasts
05:50am, Saturday, 25'th Apr 2020
Ionis Pharmaceuticals Inc (NASDAQ:IONS) – Stock analysts at William Blair cut their Q1 2020 EPS estimates for shares of Ionis Pharmaceuticals in a report released on Tuesday, April 21st. William Bla
FY2023 Earnings Forecast for Ionis Pharmaceuticals Inc Issued By William Blair (NASDAQ:IONS)
10:14am, Friday, 24'th Apr 2020
Ionis Pharmaceuticals Inc (NASDAQ:IONS) – Stock analysts at William Blair upped their FY2023 EPS estimates for shares of Ionis Pharmaceuticals in a research note issued on Tuesday, April 21st. Willi
